Charlotte Irvine

Counsel

Areas of Focus

Charlotte Irvine

Counsel

charlotte.irvine@akingump.com

Areas of Focus

Save as PDF

Share This Biography

Biography
  • Represents clients and investors across a range of transaction types, with a particular focus on technology.
  • Experience advising clients on cross-border M&A, corporate re-organisations and private equity and venture capital financing.

Charlotte is a Counsel in Akin's technology transactions group , based in the London corporate practice. Her practice concentrates on cross border and domestic mergers and acquisitions (M&A) and private equity and venture capital financing. Charlotte has acted for trade buyers, high-growth companies, portfolio companies, founders, investors and management teams.

She has experience across a range of industry sectors, including artificial intelligence (AI)/ machine learning, information technology (IT) infrastructure, fintech, gaming, digital health, biotechnology and life sciences.

Charlotte has spent time on secondment at a multinational healthcare company and at a multinational hospitality company listed on the LSE and the NYSE.

Representative Work

M&A

  • Advised an iGaming software provider on its acquisition of multiple online gaming studios.
  • Advised AdvancedAdvT Ltd on its acquisition of multiple software businesses from Capita and its subsequent onward sale of one of the businesses.
  • Advised a NASDAQ-listed digital sports entertainment and gaming company on its acquisition of a UK golf pricing business.
  • Advised a US-based SaaS platform provider on its acquisition of a subscription management and live streaming platform based in the UK and Macedonia.
  • Advised a US-based global healthcare data provider on its acquisition of a UK-based SaaS provided.
  • Advised a wellbeing platform provider on its acquisition of a digital machine-learning platform.
  • Advised a cyber-security company on its acquisition of a security solutions company.
  • Advised Snyk, a leader in developer security, on its acquisition of Enso Security, an application security posture management solution developer .
  • Advised Cision, a global comprehensive communications platform, on its acquisition of Factmata, an advanced social and news media monitoring company.
  • Advised Kheiron Medical Technologies Limited, a UK-based AI cancer diagnostic company, on its sale to DeepHealth, a diagnostic imaging provider.
  • Advised ChannelAdvisor, a cloud-based e-commerce platform, on its sale to CommerceHub, a global commerce network, for $725 million.
  • Advised Quickbase, Inc. (a portfolio company of Vista Equity Partners) on its acquisition of CloudPipes, a UK and Bulgarian provider of cloud-based integration and automation platforms.
  • Advised the investor shareholders of a UK biotech company on its sale to a multinational healthcare group based in Japan.
  • Advised Smiths Group plc on the sale of the Smiths Interconnect Microwave Telecoms business to Infinite Electronics Inc.
  • Advised IHG on its arrangements with French investor Convivio to rebrand and operate 12 high-quality open hotels and one pipeline hotel in the UK following the acquisition of the hotels by Convivio from Starwood Capital Group.
  • Advised AstraZeneca AB on its agreement with Grünenthal to divest the European rights to Nexium.
  • Advised AstraZeneca AB on its agreement with Grünenthal to divest the global rights to Vimovo in all markets excluding the US and Japan.
  • Advised Macquarie Infrastructure and Real Assets on the divestment of its European rolling stock leasing business to Akiem Group.
  • Advised a high net worth individual on his acquisition of shares in a League Two football club.

Private Equity

  • Advised CovertSwarm, a cybersecurity company, on its investment from Beech Tree Private Equity.
  • Advised Burda Principal Investments on the buyout of notonthehighstreet, an online marketplace, by Great Hill Partners.
  • Advised Princeton Equity Group on its investment in Barry’s Bootcamp, a global fitness company.
  • Advised Carlyle on its agreement to acquire Altera Infrastructure Group’s FPSO Business from Brookfield.
  • Advised Vista Equity Partners on the acquisition of Advanced, a UK software company, in conjunction with BC Partners.

Venture Capital

  • Advised Accel as lead investor in the $267 million Series F fundraising of Zepz, a private digital payments company.
  • Advised QED Investors on its investment into various technology companies.
  • Advised Exscientia, an AI-driven pharmatech company, on its Series D funding round and subsequent $510.4 million initial public offering.
  • Advised Oribiotech Ltd, a cell and gene therapy manufacturing technology company, on its £23 million Series A financing led by Northpond Ventures in a syndicate including Octopus Ventures, Delin Ventures and Amadeus.
  • Advised Bit Bio, a synthetic biology company, on its $41 million Series A financing.
  • Advised various other technology and life sciences companies on their early to late state funding rounds.

Other

  • Advised Redx Pharma, a UK clinical-stage biotechnology company, on its all share merger with Jounce Therapeutics, a US clinical-stage immunotherapy company, in a $425 million and contingent value right transaction.
  • Advised Kore Potash plc on its re-domicile to the United Kingdom (by way of a scheme of arrangement) and subsequent listing on the AIM Market of the London Stock Exchange.

*List includes matters worked on prior to joining Akin.

Education
  • L.P.C., The College of Law, Guildford, 2015

  • GDL, University of Law, London, 2014

  • B.A., University of Warwick, 2013

Bar Admissions
  • Solicitor, England and Wales

Insights and Achievements

      Related Content

      People

      Distinguished by our areas of focus, as a cohesive and integrated firm, we are defined by the caliber of our work, the responsiveness of our service and a culture that is rooted in collaboration and forward-thinking.

      We Also Recommend

      Loading...
      Loading...
      Loading...
      Loading...